Israel - Light onto Nations is an initiative, not a media watch organization. It is web-based and does not involve fundraising.

Israel - Light onto Nations endorses various Canadian media-watch organizations, such as: CLIC - Canadian Light on Israel Coverage, Honest Reporting ( and The Media Action Group (

Did You Know?

Israel engineers are behind the development of the largest communications router in the world, launched by Cisco.

Tuesday, January 18, 2011

BrainsGate Breakthrough

Established in 2000, BrainsGate is a medical device company committed to developing innovative therapies for patients suffering from Central Nervous System (CNS) diseases.

BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow.

BrainsGate is exploring several applications for its technology, and is currently focusing on two directions: treatment of acute ischemic stroke, and chronic SPG stimulation to treat vascular dementia patients.

Building on its technology, the Company has developed the ISS, based on a miniature electrode implanted at the roof of the mouth in a minimally invasive, local anesthesia procedure comparable to dental treatment.

In 2008, the Company has completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. BrainsGate is now running ImPACT-24, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24 hour window.

BrainsGate's investors include Johnson & Johnson, Boston Scientific, Elron Electronics Industries, Pitango Venture Capital, Alice Ventures, Agate Medical Investments, and Infinity Ventures. BrainsGate is headquartered in Caesarea, Israel.

BrainsGate Breakthrough